Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 7/20 | 0.42 |
| ▸ | PLK1 | P53350 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | STAT6 | P42226 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24397029 | 0.85 | HPGDS (0.48) | HPGDSMRGPRX4CDC25BFABP4PLK1 | |
| SCHEMBL24397030 | 0.85 | HPGDS (0.42) | HPGDSMRGPRX4CDC25BFABP4PLK1 | |
| SCHEMBL24397095 | 0.83 | CDC25B (0.45) | HPGDSMRGPRX4CDC25BFABP4PLK1 | |
| SCHEMBL24397098 | 0.80 | CDC25B (0.42) | HPGDSCDC25BFABP4PLK1MAPT | |
| SCHEMBL24397309 | 0.80 | CDC25B (0.42) | HPGDSCDC25BFABP4PLK1MAPT | |
| SCHEMBL87769 | 0.78 | CDC25B (0.49) | HPGDSMRGPRX4CDC25BPLK1MAPT | |
| SCHEMBL24397526 | 0.77 | CDC25B (0.54) | HPGDSMRGPRX4CDC25BPLK1MAPT | |
| SCHEMBL14836952 | 0.77 | CDC25B (0.54) | HPGDSMRGPRX4CDC25BPLK1MAPT | |
| SCHEMBL24396992 | 0.76 | AVPR2 (0.41) | HPGDSCDC25BFABP4PLK1MAPT | |
| SCHEMBL10998646 | 0.76 | F2 (0.43) | MAPTKMT2AHPGDALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220137507-A1 | COMPOUND, ACID GENERATOR, COMPOSITION, CURED PRODUCT, CURED PRODUCT MANUFACTURING METHOD, AND PATTERN COATING MANUFACTURING METHOD | ADEKA CORPORATION (JP) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220137507-A1 | COMPOUND, ACID GENERATOR, COMPOSITION, CURED PRODUCT, CURED PRODUCT MANUFACTURING METHOD, AND PATTERN COATING MANUFACTURING METHOD | H1-0, H1-4, HRH1 | HPGDS 746/4885MRGPRX4 1574/4885CDC25B 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.